These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6890583)

  • 1. A phosphorylated basic vaccinia virion polypeptide of molecular weight 11,000 is exposed on the surface of mature particles and interacts with actin-containing cytoskeletal elements.
    Hiller G; Weber K
    J Virol; 1982 Nov; 44(2):647-57. PubMed ID: 6890583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoprotein component of vaccinia virions.
    Rosemond H; Moss B
    J Virol; 1973 Jun; 11(6):961-70. PubMed ID: 4712965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion.
    Essani K; Dales S
    Virology; 1979 Jun; 95(2):385-94. PubMed ID: 462799
    [No Abstract]   [Full Text] [Related]  

  • 4. The virion and soluble antigen proteins of variola, monkeypox, and vaccinia viruses.
    Esposito JJ; Obijeski JF; Nakano JH
    J Med Virol; 1977; 1(2):95-110. PubMed ID: 205632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vaccinia virus 4c and A-type inclusion proteins are specific markers for the intracellular mature virus particle.
    Ulaeto D; Grosenbach D; Hruby DE
    J Virol; 1996 Jun; 70(6):3372-7. PubMed ID: 8648667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of vaccinia virus by zonal centrifugation and analysis of viral protein composition.
    Madaliński W; Bańkovski A; Korbecki M
    Acta Virol; 1977 Mar; 21(2):104-8. PubMed ID: 17277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the nature and location of the capsid polypeptides of vaccinia virions.
    Sarov I; Joklik WK
    Virology; 1972 Nov; 50(2):579-92. PubMed ID: 4117937
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a virus-specified protein in the nucleus of vaccinia virus-infected cells.
    Hruby DE; Lynn DL; Kates JR
    J Gen Virol; 1980 Apr; 47(2):293-9. PubMed ID: 7365469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus.
    Roby C; Gibson W
    J Virol; 1986 Sep; 59(3):714-27. PubMed ID: 3016333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a DNA-binding phosphoprotein from vaccinia virus replication complex.
    Nowakowski M; Bauer W; Kates J
    Virology; 1978 May; 86(1):217-25. PubMed ID: 208247
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycoprotein synthesis in cells infected with vaccinia virus. 3. Purification and biosynthesis of the virion glycoprotein.
    Moss B; Rosenblum EN; Garon CF
    Virology; 1973 Sep; 55(1):143-56. PubMed ID: 4728825
    [No Abstract]   [Full Text] [Related]  

  • 12. DNA-binding proteins in the cytoplasm of vaccinia virus-infected mouse L-cells.
    Soloski MJ; Esteban M; Holowczak JA
    J Virol; 1978 Jan; 25(1):263-73. PubMed ID: 202739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinia virus antigens on the plasma membrane of infected cells. I. Viral antigens transferred from infecting virus particles and synthesized after infection.
    Mallon V; Holowczak JA
    Virology; 1985 Mar; 141(2):201-20. PubMed ID: 4082499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and location of the major glycoprotein of vaccinia virus.
    Boisvert J; Yamamoto T
    Microbios; 1976; 16(63):55-72. PubMed ID: 1026850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and molecular anatomy of the varicella-zoster virion.
    Grose C; Friedrichs WE; Smith GC
    Biken J; 1983 Mar; 26(1):1-15. PubMed ID: 6312957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65.
    Sodeik B; Griffiths G; Ericsson M; Moss B; Doms RW
    J Virol; 1994 Feb; 68(2):1103-14. PubMed ID: 8289340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release.
    Hiller G; Eibl H; Weber K
    J Virol; 1981 Sep; 39(3):903-13. PubMed ID: 7288920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus.
    Maa JS; Esteban M
    J Virol; 1987 Dec; 61(12):3910-9. PubMed ID: 3316708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia virus structural polypeptide derived from a high-molecular-weight precursor: formation and integration into virus particles.
    Katz E; Moss B
    J Virol; 1970 Dec; 6(6):717-26. PubMed ID: 4250367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunolocalization of vaccinia virus structural proteins during virion formation.
    Vanslyke JK; Hruby DE
    Virology; 1994 Feb; 198(2):624-35. PubMed ID: 8291244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.